Nov 05, 2020 / 10:00PM GMT
Operator
Good afternoon, and welcome to Assembly Bio's Phase II Expansion Study Update Webcast and Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to hand the call over to Lauren Glaser, Senior Vice President of Investor Relations and Corporate Affairs for Assembly Bio. Please go ahead.
Lauren Glaser - Assembly Biosciences, Inc. - SVP of IR & Corporate Affairs
Good afternoon, and thank you for joining us as we discuss interim results from Study 211, our Phase II extension study, monitoring patients with chronic hepatitis B virus for sustained virologic response or SVR, following discontinuation of treatment with vebicorvir and a nucleoside analogue.
This afternoon, we issued a press release providing an update on this ongoing study as well as a second press release reporting our financial results for the third quarter ended September 30, 2020. These press releases are available in the News and Events section of our corporate website at
Assembly Biosciences, Inc. - Special Call Transcript
Nov 06, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers